Latest News and Press Releases

CAMBRIDGE, U.K., Oct. 31, 2003 (PRIMEZONE) -- Astex Technology Ltd, the fragment-based drug discovery company, today announced that it is to merge with Berlin-based oncology specialist, metaGen...

CAMBRIDGE, United Kingdom, Sept. 22, 2003 (PRIMEZONE) -- Astex Technology, (Other OTC:FJSPF) the fragment-based drug discovery company, today announced that it has received the first research and...

CAMBRIDGE, U.K., August 19, 2003 (PRIMEZONE) -- Astex Technology Ltd, the fragment-based drug discovery company, and Fujisawa Pharmaceutical Co., Ltd, (Other OTC:FJSPF) today announced a structural...

CAMBRIDGE, U.K., July 11, 2003 (PRIMEZONE) -- Astex Technology, the fragment-based drug discovery company, today announced the official opening of its new, 36,000 ft2 research and development...

CAMBRIDGE, U.K., July 7, 2003 (PRIMEZONE) -- Astex Technology, the fragment-based drug discovery company, today announced that it has extended its existing research collaboration agreement with...

CAMBRIDGE, U.K., June 12, 2003 (PRIMEZONE) -- Astex Technology, the fragment-based drug discovery company, today announced that its scientists have made a major discovery relating to a key protein...

CAMBRIDGE, United Kingdom, May 6, 2003 (PRIMEZONE) -- Astex Technology, the fragment-based drug discovery company and Schering AG (FSE:SCH) NYSE:SHR), today announced a major multi-target drug...

CAMBRIDGE, U.K., March 20, 2003 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company, today announced an exclusive research collaboration and licence agreement with the...

CAMBRIDGE, U.K., March 3, 2003 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company, today announced a collaboration with AstraZeneca. The agreement relates to the discovery of...

CAMBRIDGE, U.K., Jan. 22, 2003 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company, today announced the appointment of Dr. David Rees to the position of Director of Medicinal...